SECTOR ANALYSIS

Sleep Rare Disease Biotech Companies

Grades, scores, and FDA catalyst signals for Sleep Rare Disease stocks tracked by BiotechSign

← Full Screener FDA Calendar All Sectors

Companies

Avg Score

Top Grade

Sleep Rare Disease Companies— 13 tracked

Ticker	Company	Score	Grade	Sector	Signals
AGIO	Agios Pharmaceuticals	62	C	Rare Disease	—
FOLD	Amicus Therapeutics	57	C	Rare Disease	—
INSM	Insmed Incorporated	57	C	Rare Disease	—
BCRX	BioCryst Pharmaceuticals	56	C	Rare Disease	—
PTCT	PTC Therapeutics	55	C	Rare Disease	—
BMRN	BioMarin Pharmaceutical	53	C	Rare Disease	—
RARE	Ultragenyx Pharmaceutical	47	D	Rare Disease	—
PHVS	Pharvaris NV	37	D	Rare Disease	—
PRQR	ProQR Therapeutics	35	F	Rare Disease	—
KNSA	Kiniksa Pharmaceuticals	31	F	Rare Disease	—
LRMR	Larimar Therapeutics	29	F	Rare Disease	—
STOK	Stoke Therapeutics	29	F	Rare Disease	—
DSGN	Design Therapeutics	23	F	Rare Disease	—

Not financial advice. All data and analysis provided by Guerilla Finance Inc. BiotechSign grades and scores are algorithmic signals only and do not constitute investment recommendations. Biotech investing involves significant risk, including the potential for complete loss of capital on binary FDA events. Always conduct your own due diligence before making investment decisions.